Related Experiment Video
Updated: Jun 10, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway
Jing Ning1, Xiubing Chen2, Qing Li1
1Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Abstract:
Cancer patients commonly use morphine to alleviate advanced pain. Studies have shown that morphine may influence and intervene in the malignancy of various cancers, but its role and effects on pancreatic cancer are less studied. This study aims to examine how morphine affects pancreatic cancer and its possible mechanisms. In vitro experiments were conducted using the CCK-8 experiment, colony formation experiment, EdU test, wound healing experiment, and transwell migration and invasion experiment. Tumor xenograft tests were employed to investigate the in vivo impact of morphine on pancreatic cancer. The Western blot (WB) assay was used to detect possible changes in key proteins of the related signaling pathway. Our experimental results showed that low concentrations of morphine (25 µM) promoted the progression of pancreatic cancer, while high concentrations of morphine (100 µM) inhibited its progression. Further, we demonstrated that morphine may interfere with the progression of pancreatic cancer by acting on the p38/JNK signaling pathway. Morphine may affect pancreatic cancer progression through the p38/JNK pathway in a bidirectional manner at different concentrations.
Insights
Morphine
Area of Science:
- Oncology
- Pharmacology
Background:
- Morphine is a common analgesic for advanced cancer pain.
- Its impact on pancreatic cancer progression and mechanisms remains under-investigated.
Purpose of the Study:
- To investigate the effects of morphine on pancreatic cancer progression.
- To elucidate the underlying molecular mechanisms, particularly the p38/JNK signaling pathway.
Main Methods:
- In vitro assays (CCK-8, colony formation, EdU, wound healing, Transwell).
- In vivo tumor xenograft models.
- Western blot analysis of signaling pathway proteins.
Main Results:
- Low morphine concentrations (25 µM) promoted pancreatic cancer progression.
- High morphine concentrations (100 µM) inhibited pancreatic cancer progression.
- Morphine modulated the p38/JNK signaling pathway.
Conclusions:
- Morphine exhibits a bidirectional effect on pancreatic cancer progression based on concentration.
- The p38/JNK pathway is implicated in morphine's influence on pancreatic cancer.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Analgesia and Pain Management
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

